Argenx price target lowered to $1,227 from $1,248 at Stifel

Stifel lowered the firm’s price target on Argenx (ARGX) to $1,227 from $1,248 and keeps a Buy rating on the shares. The Vyvgart launch remains strong with the franchise now annualizing over $5B in global revenue, the analyst tells investors in a research note. To that end, the firm thinks consistent management commentary on the trajectory in 2026 and beyond suggests that current consensus of $5.7B is toto conservative even amid increasing competition and Q1 seasonality.